
Xeureka Inc. is a Japanese company leveraging cutting-edge AI and simulation technologies to significantly improve efficiency and success rates in drug discovery research. They provide AI drug discovery support services and conduct joint research and development aimed at creating new drugs. Their technology includes target analysis, ultra-large scale virtual screening, free energy perturbation, and AI & simulation for drug design. Xeureka plans to expand from analysis services to software sales and SaaS offerings. The company is positioned as an innovator in the pharmaceutical industry, supported by Mitsui & Co., and aims to deliver better, affordable medicines quickly to patients suffering from diseases.

Xeureka Inc. is a Japanese company leveraging cutting-edge AI and simulation technologies to significantly improve efficiency and success rates in drug discovery research. They provide AI drug discovery support services and conduct joint research and development aimed at creating new drugs. Their technology includes target analysis, ultra-large scale virtual screening, free energy perturbation, and AI & simulation for drug design. Xeureka plans to expand from analysis services to software sales and SaaS offerings. The company is positioned as an innovator in the pharmaceutical industry, supported by Mitsui & Co., and aims to deliver better, affordable medicines quickly to patients suffering from diseases.